Simply Wall St.
3 Stocks That Investors Might Be Undervaluing By Up To 32.3%
📈
AI Sentiment
Highly Positive
9/10
- Home
- BLFS
as of 12-26-2025 3:40pm EST
$24.92
$0.49
-1.93%
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
| Founded: | 1987 | Country: | United States |
| Employees: | N/A | City: | BOTHELL |
| Market Cap: | 1.2B | IPO Year: | 1989 |
| Target Price: | $31.50 | AVG Volume (30 days): | 319.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.07 | EPS Growth: | N/A |
| 52 Week Low/High: | $19.10 - $29.62 | Next Earning Date: | 11-06-2025 |
| Revenue: | $100,144,000 | Revenue Growth: | 87.53% |
| Revenue Growth (this year): | 20.67% | Revenue Growth (next year): | 14.13% |
AI-Powered BLFS Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 3 days ago
AI Recommendation
hold
Model Accuracy: 66.23%
66.23%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of BioLife Solutions Inc. (BLFS)
Aebersold Sarah
Sell
Chief Human Resources Officer
BLFS Dec 15, 2025
Avg Cost/Share
$24.46
Shares
713
Total Value
$17,439.98
Owned After
76,006
SEC Form 4
DuRoss Amy
Sell
Director
BLFS Dec 15, 2025
Avg Cost/Share
$24.60
Shares
2,000
Total Value
$49,200.00
Owned After
18,687
SEC Form 4
Aebersold Sarah
Sell
Chief Human Resources Officer
BLFS Dec 9, 2025
Avg Cost/Share
$25.13
Shares
233
Total Value
$5,855.29
Owned After
76,006
SEC Form 4
Berard Todd
Sell
Chief Marketing Officer
BLFS Dec 9, 2025
Avg Cost/Share
$25.13
Shares
358
Total Value
$8,996.54
Owned After
132,908
SEC Form 4
Foster Karen A.
Sell
Chief Quality and Operations
BLFS Dec 9, 2025
Avg Cost/Share
$25.13
Shares
519
Total Value
$13,042.47
Owned After
192,319
SEC Form 4
Mathew Aby J.
Sell
EVP & Chief Scientific Officer
BLFS Dec 9, 2025
Avg Cost/Share
$25.13
Shares
631
Total Value
$15,857.03
Owned After
349,755
SEC Form 4
Wichterman Troy
Sell
Chief Financial Officer
BLFS Dec 9, 2025
Avg Cost/Share
$25.13
Shares
1,033
Total Value
$25,959.29
Owned After
151,736
SEC Form 4
DE GREEF RODERICK
Sell
President and CEO
BLFS Nov 13, 2025
Avg Cost/Share
$25.33
Shares
31,165
Total Value
$789,409.45
Owned After
389,998
SEC Form 4
DE GREEF RODERICK
Sell
President and CEO
BLFS Nov 12, 2025
Avg Cost/Share
$25.88
Shares
33,418
Total Value
$864,857.84
Owned After
389,998
SEC Form 4
DE GREEF RODERICK
Sell
President and CEO
BLFS Nov 11, 2025
Avg Cost/Share
$26.15
Shares
35,417
Total Value
$926,154.55
Owned After
389,998
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Aebersold Sarah | BLFS | Chief Human Resources Officer | Dec 15, 2025 | Sell | $24.46 | 713 | $17,439.98 | 76,006 | |
| DuRoss Amy | BLFS | Director | Dec 15, 2025 | Sell | $24.60 | 2,000 | $49,200.00 | 18,687 | |
| Aebersold Sarah | BLFS | Chief Human Resources Officer | Dec 9, 2025 | Sell | $25.13 | 233 | $5,855.29 | 76,006 | |
| Berard Todd | BLFS | Chief Marketing Officer | Dec 9, 2025 | Sell | $25.13 | 358 | $8,996.54 | 132,908 | |
| Foster Karen A. | BLFS | Chief Quality and Operations | Dec 9, 2025 | Sell | $25.13 | 519 | $13,042.47 | 192,319 | |
| Mathew Aby J. | BLFS | EVP & Chief Scientific Officer | Dec 9, 2025 | Sell | $25.13 | 631 | $15,857.03 | 349,755 | |
| Wichterman Troy | BLFS | Chief Financial Officer | Dec 9, 2025 | Sell | $25.13 | 1,033 | $25,959.29 | 151,736 | |
| DE GREEF RODERICK | BLFS | President and CEO | Nov 13, 2025 | Sell | $25.33 | 31,165 | $789,409.45 | 389,998 | |
| DE GREEF RODERICK | BLFS | President and CEO | Nov 12, 2025 | Sell | $25.88 | 33,418 | $864,857.84 | 389,998 | |
| DE GREEF RODERICK | BLFS | President and CEO | Nov 11, 2025 | Sell | $26.15 | 35,417 | $926,154.55 | 389,998 |
Latest BioLife Solutions Inc. News
BLFS Breaking Stock News: Dive into BLFS Ticker-Specific Updates for Smart Investing
Simply Wall St.
3 Stocks That May Be Priced Below Their Estimated Worth In December 2025
📈
AI Sentiment
Highly Positive
9/10
Simply Wall St.
3 Stocks Estimated To Be Trading Below Their Intrinsic Value In December 2025
📈
AI Sentiment
Highly Positive
8/10
Simply Wall St.
Undervalued Equities That May Offer Value In December 2025
📈
AI Sentiment
Highly Positive
8/10
Compare BLFS vs Leading Stocks
See how BLFS stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "BLFS BioLife Solutions Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.